James Durecka
Chief Financial Officer
Replay available
TherapeuticsMD, Inc. (TXMD) Q2 2021 Earnings Call
TherapeuticsMD, Inc. (NASDAQ: TXMD) Q2 2021 earnings conference call, held 2021-08-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Doug LaSalle
Analyst, HC Wainwright
Rob Fenizio
Chief Executive Officer
Lisa Wilson
Investor Relations, TherapeuticsMD
Don Halkoff
Chief Commercial Officer
Louise Chen
Analyst, Cantor
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Therapeuticsmd, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.009 -- 00:00:04.332 Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD second 00:00:04.332 -- 00:00:07.674 quarter 2021 financial results conference call. 00:00:07.674 -- 00:00:11.476 Following prepared remarks from the company, we will open the call for questions. 00:00:11.476 -- 00:00:15.539 I would now like to turn the call over to Investor Relations for TherapeuticsMD, Lisa 00:00:15.539 -- 00:00:18.059 Wilson. Lisa? 00:00:18.281 -- 00:00:22.503 Thank you, Christy. Good morning, everyone, and thank you for joining us today to discuss 00:00:22.503 -- 00:00:26.232 our second quarter financial results and business updates. 00:00:26.232 -- 00:00:30.875 This morning, TherapeuticsMD issued a press release announcing our second quarter financial 00:00:30.875 -- 00:00:32.316 results. 00:00:32.316 -- 00:00:36.979 The press release is available on the company's website, therapeuticsmd.com, 00:00:36.979 -- 00:00:40.380 in the Investors and Media section. 00:00:40.401 -- 00:00:45.604 On today's call from TherapeuticsMD are Chief Executive Officer Rob Fenizio, 00:00:45.604 -- 00:00:48.966 Chief Financial Officer James Durecka, 00:00:48.966 -- 00:00:54.490 Chief Commercial Officer Don Halkoff, and Chief Strategy and Performance Officer 00:00:54.490 -- 00:00:56.525 Mitchell Crassens. 00:00:56.525 -- 00:01:01.508 I would like to remind everyone that certain statements made during this conference call 00:01:01.508 -- 00:01:06.850 may be forward-looking statements. Such forward-looking statements are based upon current 00:01:06.850 -- 00:01:08.451 expectations 00:01:08.451 -- 00:01:11.873 and there can be no assurance that the results contemplated in these statements will 00:01:11.873 -- 00:01:13.614 be realized. 00:01:13.614 -- 00:0...